Effect of acetaminophen on international normalized ratio in patients receiving warfarin therapy

Pharmacotherapy

Volumn 31, Issue 6, 2011, Pages 591-597

  Hughes, Gregory J ^a   Patel, Priti N ^a   Saxena, Neera ^b  

^a ST JOHN'S UNIVERSITY   (United States)

^b Risoldi's Pharmacy   (United States)

Author keywords

Acetaminophen; Anticoagulant; Drug drug interaction; INR; International normalized ratio; Paracetamol; Vitamin K antagonist; Warfarin

Indexed keywords

COCODAMOL; FRESH FROZEN PLASMA; PARACETAMOL; PLACEBO; VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; BACKACHE; BLEEDING; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG INHIBITION; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG MONITORING; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; FEVER; GASTROINTESTINAL HEMORRHAGE; GENETIC POLYMORPHISM; GINGIVA BLEEDING; HEART ATRIUM FIBRILLATION; HEMATURIA; HUMAN; HYPERCOAGULABILITY; INTERNATIONAL NORMALIZED RATIO; KNEE PAIN; LIVER FUNCTION TEST; LIVER METABOLISM; MEDLINE; PAIN; PATIENT EDUCATION; PHARMACOGENETICS; PLASMA TRANSFUSION; PROTHROMBIN TIME; RETROPERITONEAL HEMATOMA; REVIEW; SKIN BRUISING; STROKE; SYSTEMATIC REVIEW; THROMBOEMBOLISM; THROMBOSIS;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANTICOAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG MONITORING; HUMANS; INTERNATIONAL NORMALIZED RATIO; WARFARIN;

EID: 79957588398     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.31.6.591     Document Type: Review

References (23)

1. Remington T. Headache and muscle and joint pain. In: Berardi RR, McDermott JH, Newton GD, et al, eds. Handbook of nonprescription drugs. 14th ed. Washington, DC: American Pharmacists Association, 2004:87.
2. Bristol-Myers Squibb. Coumadin (warfarin) package insert. Princeton, NJ; 2010.
3. Goldshield Pharmaceuticals, Ltd. Marevan (warfarin) summary of product characteristics. Croydon, United Kingdom; 2005.
4. Wittkowsky AK, Boccuzzi SJ, Wogen J, Wygant G, Patel P, Hauch O. Frequency of concurrent use of warfarin with potentially interacting drugs. Pharmacotherapy 2004;24:1668-74. (Pubitemid 39578956)
5. Launiainen T, Sajantila A, Rasanen I, Vuori E, Ojanpera I. Adverse interaction of warfarin and paracetamol: evidence from a post-mortem study. Eur J Clin Pharmacol 2010;66:97-103.
6. Drug Topics. 2009 top 200 generic drugs by total prescriptions. Available from http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard// drugtopics/252010/674982/article.pdf. Accessed August 10, 2010.
7. Bartle WR, Blakely JA. Potentiation of warfarin anticoagulation by acetaminophen [case report]. JAMA 1991;265:1260.
8. Fitzmaurice DA, Murray JA. Potentiation of the anticoagulant effect of warfarin. Postgrad Med J 1997;73:439-40. (Pubitemid 27361981)
9. Andrews FJ. Retroperitoneal haematoma after paracetamol increased anticoagulation. Emerg Med J 2002;19:84-5. (Pubitemid 34092556)
10. Gebauer MG, Nyfort-Hansen K, Henschke PJ, Gallus AS. Warfarin and acetaminophen interaction. Pharmacotherapy 2003;23:109-12. (Pubitemid 36077374)
11. Dharmarajan L, Sajjad W. Potentially lethal acetaminophen-warfarin interaction in an older adult: an under-recognized phenomenon? J Am Med Dir Assoc 2007;8:545-7. (Pubitemid 47528134)
12. Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 1998;279:657-62. (Pubitemid 28138733)
13. Bell WR. Acetaminophen and warfarin: undesirable synergy. JAMA 1998;279:702-3. (Pubitemid 28138741)
14. Estrada C, Gray CD, Amato MG, et al. Acetaminophen and risk factors for excess anticoagulation with warfarin. JAMA 1998;280:695-7. (Pubitemid 28405291)
15. Shalansky S, Lynd L, Richardson K, Ingaszewski A, Kerr C. Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis. Pharmacotherapy 2007;27:1237-47. (Pubitemid 47339121)
16. Mahé I, Bertrand N, Drouet L, et al. Paracetamol: a haemorrhagic risk factor in patients on warfarin. Br J Clin Pharmacol 2004;59:371-4.
17. Mahé I, Bertrand N, Drouet L, et al. Interaction between paracetamol and warfarin in patients: a double-blind, placebocontrolled, randomized study. Haematologica 2006;91:1621-7. (Pubitemid 46032959)
18. Parra D, Beckey NP, Stevens GR. The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy. Pharmacotherapy 2007;27:675-83. (Pubitemid 46700959)
19. Shek KL, Chan LN, Nutescu E. Warfarin-acetaminophen drug interaction revisited. Pharmacotherapy 1999;19:1153-8. (Pubitemid 29455936)
20. Lehmann DF. Enzymatic shunting: resolving the acetaminophen-warfarin controversy. Pharmacotherapy 2000;20:1464-8.
21. Whyte IM, Buckley NA, Reith DM, Goodhew I, Seldon M, Dawson AH. Acetaminophen causes an increased international normalized ratio by reducing functional factor VII. Ther Drug Monit 2000;22:742-8.
22. Kwan D, Bartle WR, Walker SE. The effects of acetaminophen on pharmacokinetics and pharmacodynamics of warfarin. J Clin Pharmacol 1999;39:68-75. (Pubitemid 29053154)
23. Ansell J, Hirsch J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists. Chest 2008;133:S160-98.